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Abstract
A long-term program of surveillance of antimicrobial resistance in Neisseria gonorrhoeae isolated in the World
Health Organization’s Western Pacific Region (WHO WPR GASP) continued in 2000. About 11,000 gonococci
were examined in 15 focal points. Widespread resistance to the penicillin group of antibiotics was confirmed.
Resistance to quinolone antibiotics, already widely dispersed, increased further with a shift to higher levels of
resistance in many centres. Gonococci with decreased susceptibility to third generation cephalosporins were
observed in 5 centres. Spectinomycin resistance was infrequently encountered. Options for cheap and effective
treatment of gonorrhoea in the WPR are increasingly limited. Commun Dis Intell 2001;25:274-277.
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Introduction
Early and successful antibiotic treatment of gonococcal
infection is important not only for the individual patient but is
also a significant factor in control of disease and the
prevention of complications. The ability of Neisseria
gonorrhoeae to become resistant to cheap and effective
antibiotics is well recognised and has significantly compro-
mised both individual and public health management of
gonorrhoea. Because treatment of gonorrhoea is best given
as single dose treatment on initial diagnosis, standardised
treatment schedules have been established. However,
antibiotic resistance in the gonococcus can arise quickly. It
is therefore important to have available accurate data on
antimicrobial resistance in the gonococcus in order to guide
selection of an appropriate antibiotic treatment. Antibiotic
resistance in gonococci often spreads rapidly between
countries, and infected travellers often present for treatment
in countries distant from the place of contact. Thus for a
number of reasons it is important to have available regional
as well as local data on antibiotic resistance.
The WHO Western Pacific Region (WPR) Gonococcal Anti-
microbial Surveillance Programme (GASP) is a continuing
program of susceptibility surveillance in the Region and has
published surveillance data annually since 1992.1 The
Region has an unfortunate history of development of anti-
microbial resistance in gonococci with penicillin, spectin-
omycin and quinolone resistant N. gonorrhoeae all
appearing in and spreading beyond the WPR. This
communication provides an analysis of surveillance of
antimicrobial resistance in N. gonorrhoeae in the WHO
WPR in 2000.
Methods
The methods used by the WHO WPR GASP have been
published2 and provide full details of the source of isolates,
sample populations, laboratory test methods and quality
assurance programs used to generate data. These methods
were unaltered in 2000. Most isolates were collected from
symptomatic STD clinic patients. As a guide to the
interpretation of the following data, a WHO expert
committee has recommended that treatment regimens be
altered once resistance to a particular antibiotic reaches
5 per cent.3
Results and discussion
About 10,500 gonococcal isolates were examined in
15 participating countries (listed in the acknowledgments) in
2000.
Resistance to the penicillins remained widespread by both
chromosomal (CMRNG) and plasmid mediated mechan-
isms (penicillinase producing N. gonorrhoeae — PPNG).
Table 1 provides details of CMRNG, PPNG and/or total
penicillin resistance in 15 WPR focal points. Very high
proportions of combined forms of penicillin resistance
(CMRNG + PPNG) were recorded in Korea (91%), the
Philippines (89%), China (80%), Brunei (63%), Singapore
(58%), Hong Kong SAR (54%), and Vietnam (48%). With the
exception of the Hong Kong SAR and Vietnam where
penicillin resistance declined somewhat, these proportions
approximated those found in preceding years. Apart from
New Caledonia (no penicillin resistance), Papua New
Guinea (36.5% of strains penicillin resistance), and Tonga
(no penicillin resistance), data from some Pacific Island
states were unavailable this year. With the exception of
Papua New Guinea, low levels of penicillin resistant were
observed in these countries in past years. Other participants
submitting data in 2000 (Australia, Japan and New Zealand)
had proportions of penicillin resistance between 8 and 28
per cent. Malaysia had a high proportion of isolates showing
resistance in a small sample.
Resistance to the quinolone antibiotics remained a major
problem in many parts of the WPR and the situation
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deteriorated further in 2000. Data from 12 WPR countries
are shown in Table 2 and quinolone resistant strains
(QRNG) are divided into ‘less susceptible’ and ‘resistant’
categories on the basis of susceptibility determinations.
Eleven of 12 WPR countries which examined isolates for
quinolone resistance detected QRNG in 2000. High
proportions of QRNG were detected in China, Hong Kong,
the Philippines, Japan and Vietnam maintaining a situation
observed in previous reports. In the above countries and
also in Korea and Australia, the proportion of strains fully
resistant to quinolone antibiotics increased while the
proportion of less sensitive isolates decreased, i.e. there
was again an upward shift in overall levels of resistance. In
Hong Kong the percentage of ‘resistant’ QRNG has
increased from about 50 per cent in 1998 to about 66 per
cent in 1999 to 80 per cent in 2000 and in China quinolone
resistance rates again increased markedly in an expanded
sample. A shift to higher MICs in Japan saw the proportion of
‘resistant’ QRNG there increase from about 23 per cent in
1999 to 40 per cent in 2000. In Brunei the proportion of
QRNG was essentially unchanged from previous years.
An ominous trend was the presence of a small number of
isolates with altered susceptibility to third generation cephal-
osporins. These strains were seen in Singapore, Brunei,
China, Australia and New Zealand. Because of method-
ological differences in testing, MIC values are not directly
comparable between centres, but values ranged up to 0.25
mg/L. Third generation cephalosporins are crucially
important agents in the treatment of gonorrhoea as resist-
ance to other agents accelerates.
A small number of spectinomycin resistant strains were
found in China, Papua New Guinea, Vietnam, Brunei and
Korea. Only very occasional strains resistant to this
injectable antibiotic have been found in recent WPR
surveys.
Although tetracyclines are not a recommended treatment for
gonorrhoea, these agents are widely used and readily
available in the WPR. One particular type of plasmid-
mediated resistance gives rise to high-level tetracycline
resistance (TRNG). About 6,900 gonococci were examined
for high-level tetracycline resistance in 12 WPR countries in
2000 (Table 3). High proportions of TRNG isolates were
again prominent in Malaysia, Brunei, Singapore, Vietnam,
China and Papua New Guinea ranging between 25 and 70
per cent. In other countries the proportions of TRNG ranged
between 0.5 and 11 per cent of strains examined. The
proportion of TRNG has increased significantly in China in
recent years from around 3 per cent in 1998 to nearly 15 per
cent in 1999 to 25 per cent in 2000.
The data recorded in 2000 in the WPR indicate that further
increases in gonococcal resistance to antibiotics have
occurred. Resistance to the penicillins is so widespread that
any contemplated use of this group of antibiotics would
require prior validation of likely efficacy. A similar
requirement would now seem to be appropriate for
quinolone antibiotics given the extensive resistance
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Table 1. Penicillin sensitivity of strains of Neisseria gonorrhoeae isolated in 15 countries in the WHO WPR,
2000
Country No. tested PPNG CMRNG All Pen R
No. % No. % No. %
Australia 3,468 302 8.7 377 10.8 679 19.5
Brunei 59 37 63.0
China 1,007 344 34.1 464 46.0 808 80.1
Fiji 756 25 3.3 3 0.3 28 3.6
Hong Kong SAR 2,743 292 10.6 1,191 43.4 1,483 54.0
Japan 213 1 0.5 59 27.6 60 28.1
Korea 190 119 62.6 54 28.4 173 91.1
Malaysia 12 9 75.0 1 8.3 10 82.6
New Caledonia 74 0 0 0 0.0
New Zealand 694 20 2.9 35 5.0 55 7.9
Papua New Guinea 224 77 34.3 5 2.2 82 36.5
Philippines 290 259 89.3 0 0.0 259 89.3
Singapore 635 349 55.0 18 2.8 367 57.8
Tonga 50 0 0.0 0 0.0 0 0.0
Vietnam 157 74 47.1 1 0.7 75 47.8
PPNG Penicillinase producing N. gonorrhoeae
CMRNG Chromosomally mediated resistance in N. gonorrhoeae
revealed in this and earlier surveys. Finding suitable
alternative treatments is difficult given the cost of suitable
antibiotics. The recognition of gonococci with altered
susceptibility to third generation cephalosporins is also a
matter of concern. Although treatment failure attributable to
resistance to this antibiotic is yet to be confirmed, there will
be considerable and continuing interest in the number of
strains which show this altered susceptibility in future
surveys and also in the MICs associated with this
phenomenon.
Acknowledgments
The following members of the WHO Western Pacific
Gonococcal Antimicrobial Surveillance Programme
supplied data in 2000 for the WPR GASP:
Members of the Australian Gonococcal Surveillance
Programme throughout Australia; HMH Kassim, Brunei,
Darussalam; Y Shunzhang and S Xiaohong, Nanjing, China;
S Bavoro, Suva, Fiji; KM Kam, Hong Kong; M Tanaka,
Fukuoka and T Kuroki, Yokohama, Japan; K Lee and Y
Chong, Seoul, Korea; R Yasin, Malaysia; B Garin, Noumea,
New Caledonia; M Brokenshire, Auckland, New Zealand;
MV Hombhanje, Port Moresby, Papua New Guinea; CC
Carlos, Manila, Philippines; C Ngan and AE Ling,
Singapore; AT Ika, Nuku’alofa, Tonga; Le Thi Phuong,
Hanoi, Vietnam.
References
1. WHO Western Pacific Region Gonococcal Surveillance
Programme. World Health Organization Western Pacific
Region Gonococcal Surveillance, 1992 annual report. Commun
Dis Intell 1994;18:61-63.
2. WHO Western Pacific Region Gonococcal Surveillance
Programme. Surveillance of antibiotic susceptibility of Neisseria
gonorrhoeae in the WHO Western Pacific Region 1992-4.
Genitourin Med 1997;73:355-361.
3. Anonymous. Management of sexually transmitted diseases.
World Health Organization 1997; Document WHO/GPA/
TEM94.1 Rev.1 p 37.
276 CDI Vol 25, No 4 November 2001
Article
Table 2. Quinolone resistance in strains of Neisseria gonorrhoeae isolated in 12 countries in the WHO WPR,
2000
Country No. tested Less susceptible Resistant
No. % No. %
Australia 3,468 334 9.6 285 8.2
Brunei 60 3 5.0 7 12.0
China 1,007 141 14.0 858 85.2
Hong Kong SAR 2,743 459 16.7 2,180 79.5
Japan 213 65 30.5 86 40.0
Korea 190 122 64.2 50 26.3
Malaysia 12 0 0
New Zealand 694 14 2.0 16 2.3
Papua New Guinea 224 0 0.0 2 0.9
Philippines 290 4 1.4 110 37.9
Singapore 635 39 6.1 121 19.0
Vietnam 157 18 11.5 67 42.7
Table 3. High level tetracycline resistance in strains
of Neisseria gonorrhoeae isolated in 11
countries in the WHO WPR in 2000
Country No. tested No. TRNG % TRNG
Australia 3,468 318 9.2
Brunei 33 24 72.0
China 1,007 260 25.8
Japan 213 1 0.5
Korea 190 5 2.6
Malaysia 12 3 25.0
New Zealand 694 23 3.3
Papua New Guinea 224 75 33.5
Philippines 290 33 11.4
Singapore 635 453 71.3
Vietnam 155 69 44.5
